From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. Cardiology>
  4. Summary and Comment

Does Nitroglycerin Response Have Diagnostic Value in the ER?

Chest-pain relief with nitroglycerin might not mean what you think it does.

Sublingual nitroglycerin is a common frontline therapy for patients with chest pain. Does symptom relief by nitroglycerin necessarily mean that the pain was caused by coronary artery disease? To answer this question, researchers prospectively studied 459 consecutive patients who presented with chest pain to the emergency department of an urban community teaching hospital and who then received sublingual or spray nitroglycerin (0.4 mg).

Symptom relief was defined as a ≥50% decrease in self-reported pain within 5 minutes of nitroglycerin administration. Active CAD was defined as any serum troponin T elevation, coronary angiography showing stenosis of ≥70%, a positive exercise-test result, or diagnosis by the attending physician with confirmation by a blinded cardiologist.

The cause of chest pain was determined to be active CAD in 31% of patients, not to be active CAD in 60%, and to be unclear in 9%. Nitroglycerin relieved chest pain in 39% of patients: 35% of those with active CAD and 41% of those without active CAD. At 4 months, the incidences of death, subsequent MI, and coronary revascularization (either individually or combined) did not differ significantly between nitroglycerin-responsive and -unresponsive patients.

Comment: These prospective, observational results suggest that in a general population admitted to an ER with chest pain, symptom relief by nitroglycerin does not predict active CAD. Therefore, response to nitroglycerin in the ER should be used cautiously as a guide to further therapy. Nitroglycerin clearly has therapeutic value, but its diagnostic value in the acute care setting is limited.

— Joel M. Gore, MD

Published in Journal Watch Cardiology February 13, 2004

Citation(s):

Henrikson CA et al. Chest pain relief by nitroglycerin does not predict active coronary artery disease. Ann Intern Med 2003 Dec 16; 139:979-86.

Gibbons RJ. Nitroglycerin: Should we still ask? Ann Intern Med 2003 Dec 16; 139:1036-7.

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. Please consider this when composing your remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Article Tools

Reader Remarks

Sign-In

Forgot your password?

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Journal Watch Newsletters

Available in 13 specialties with convenient delivery and 10 free online CME exams.

Subscribe Now!

Copyright © 2004. Massachusetts Medical Society. All rights reserved.